List of Symphogen patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10058610 Methods for treating cancer by administering humanized pan-HER antibody compositions	Patent 10058610 was granted and assigned to Symphogen on August, 2018 by the United States Patent and Trademark Office.	‌ Symphogen	‌ Symphogen	United States Patent and Trademark Office	10058610	August 28, 2018
‌ US Patent 11359018 Anti-PD-1 antibodies and compositions	Patent 11359018 was granted and assigned to Symphogen on June, 2022 by the United States Patent and Trademark Office.	‌ Symphogen	‌ Symphogen	United States Patent and Trademark Office	11359018	June 14, 2022
‌ US Patent 11390674 Anti-TIM-3 antibodies and compositions	Patent 11390674 was granted and assigned to Symphogen on July, 2022 by the United States Patent and Trademark Office.	‌ Symphogen	‌ Symphogen	United States Patent and Trademark Office	11390674	July 19, 2022
‌ US Patent 11034765 Anti-PD-1 antibodies and compositions	Patent 11034765 was granted and assigned to Symphogen on June, 2021 by the United States Patent and Trademark Office.	‌ Symphogen	‌ Symphogen	United States Patent and Trademark Office	11034765	June 15, 2021
‌ US Patent 11390676 Anti-LAG-3 antibodies and compositions	Patent 11390676 was granted and assigned to Symphogen on July, 2022 by the United States Patent and Trademark Office.	‌ Symphogen	‌ Symphogen	United States Patent and Trademark Office	11390676	July 19, 2022
‌ US Patent 9527913 Humanized pan-HER antibody compositions	Patent 9527913 was granted and assigned to Symphogen on December, 2016 by the United States Patent and Trademark Office.	‌ Symphogen	‌ Symphogen	United States Patent and Trademark Office	9527913	December 27, 2016
‌ US Patent 10450376 Anti-MET antibodies and compositions	Patent 10450376 was granted and assigned to Symphogen on October, 2019 by the United States Patent and Trademark Office.	‌ Symphogen	‌ Symphogen	United States Patent and Trademark Office	10450376	October 22, 2019
‌ US Patent 10221246 Pan-HER antibody composition	Patent 10221246 was granted and assigned to Symphogen on March, 2019 by the United States Patent and Trademark Office.	‌ Symphogen	‌ Symphogen	United States Patent and Trademark Office	10221246	March 5, 2019